Serial #79400535
LIVE

Serial Number

79400535

Owner

BGI SHENZHEN

Attorney

Charles Ho

Filing Date

Jun 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79400535 Trademark

Serial Number: 79400535 • Registration: 7717971

Serial #79400535 is a trademark filed by BGI SHENZHEN on June 3, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BGI SHENZHEN (3 trademarks)

Main Building, Beishan Industrial Zone,

Entity Type: 99

BGI Hangzhou CycloneSEQ Technology Co., Ltd.

Room 301, 3rd Floor, No. 1 Building,

Entity Type: 98

Trademark Details

Filing Date

June 3, 2024

Registration Date

March 11, 2025

Published for Opposition

January 21, 2025

Goods & Services

Computer software, recorded, for managing laboratory information, data, instruments and workflows in the field of genome sequencing; downloadable and recorded computer software for database management; data processing apparatus; laboratory devices for detecting genetic sequences; laboratory equipment, namely, protein sequence analysis apparatus; DNA microarrays; nucleic acid sequencers used for analyzing nucleic acids in scientific research; laboratory apparatus and instruments, namely, gene analyzers for detecting genetic sequences; laboratory chemical reactors; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; biochips for research or scientific purposes; DNA chips; testing apparatus not for medical purposes, namely, laboratory research apparatus for testing microscopic samples of DNA, RNA, blood, tissue and cells.

Testing apparatus for medical purposes, namely, blood testing apparatus, immunochemical testing apparatus; diagnostic apparatus for medical purposes, namely, diagnostic apparatus for testing blood sugar levels, cancer cells and DNA; apparatus for use in medical analysis; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; apparatus for blood analysis; apparatus for DNA and RNA testing for medical purposes; medical apparatus and instruments, namely, apparatus for detecting tumor, cancer and genetic diseases; medical apparatus and instruments, namely, apparatus for detecting and treating tumors and cancer; medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; probes for medical purposes; genetic testing apparatus for medical purposes; gas chromatography apparatus for medical purposes.

Biological preparations for medical purposes for detecting cancer and genetic diseases; medical diagnostic reagents for the analysis of the immune system; preparations for detecting genetic predispositions for medical purposes; reagents for use in medical genetic testing; reagent paper for medical purposes; diagnostic preparations for medical purposes; chemical preparations for medical purposes for detecting cancer and genetic diseases; enzyme preparations for medical purposes; preparations for detecting mutation in prion genes for medical purposes; diagnostic biomarker reagents for medical purposes.

Chemical reagents, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes being biological preparations for use in industry and science; test paper, chemical; biological preparations for use in cell cultures, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes.

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Apr 2, 2026 CHLD
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 8, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 24, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 24, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 12, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 15, 2025 NONP
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
Jan 10, 2025 ISCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 11, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 11, 2024 COAR
REFUSAL PROCESSED BY IB
Oct 19, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 26, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 29, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2024 REPR